Wells Fargo & Company Titan Pharmaceuticals Inc Transaction History

Wells Fargo & Company

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.26 - $0.48 $1 - $2	5 Added 5.95%	89 $0
Q3 2023 Nov 13, 2023	BUY	$0.45 - $0.66 $0 - $0	1 Added 1.2%	84 $0
Q2 2023 Aug 15, 2023	BUY	$0.65 - $0.82 $3 - $4	5 Added 6.41%	83 $0
Q1 2023 May 12, 2023	BUY	$0.73 - $1.05 $0 - $1	1 Added 1.3%	78 $0
Q4 2022 Feb 13, 2023	BUY	$0.77 - $22.8 $1 - $45	2 Added 2.67%	77 $0
Q3 2022 Nov 14, 2022	SELL	$0.53 - $22.6 $3 - $135	-6 Reduced 7.41%	75 $0
Q2 2022 Aug 12, 2022	BUY	$0.38 - $0.94 $4 - $12	13 Added 19.12%	81 $0
Q1 2022 May 16, 2022	BUY	$0.89 - $1.26 $7 - $10	8 Added 13.33%	68 $0
Q3 2021 Nov 15, 2021	BUY	$1.87 - $2.57 $26 - $35	14 Added 30.43%	60 $0
Q1 2021 May 13, 2021	BUY	$2.66 - $4.23 $2 - $4	1 Added 2.22%	46 $0
Q4 2020 Feb 09, 2021	BUY	$3.0 - $6.0 $135 - $270	45 New	45 $0

Ticker TTNP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,629,200
Market Cap $58.5M
Description
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.